- Details
- Written by White House
- Category: National News
Washington, DC - Friday, Second Lady Karen Pence traveled to San Antonio, Texas where she visited the Tracy’s Kids Art Therapy program at Methodist Children’s Hospital.
- Details
- Written by IVN
- Category: National News
Washington, DC - The Federal Trade Commission is mailing 72,836 checks totaling more than $2.9 million to people who lost money to an alleged scheme that trapped them into payday loans they never authorized or whose terms were deceptive.
- Details
- Written by White House
- Category: National News
Washington, DC - The Administration strongly opposes passage of the Schumer-Rounds-Collins Amendment. This Amendment would drastically change our national immigration policy for the worse by weakening border security and undercutting existing immigration law. Specifically, preventing enforcement with respect to people who entered our country illegally before a date that is in the future would produce a flood of new illegal immigration in the coming months. The Amendment would undermine the safety and security of American families and impede economic growth for American workers.
- Details
- Written by State Department
- Category: National News
Washington, DC - The Department of State and the U.S. Agency for International Development (USAID) published their FY 2018-2022 Joint Strategic Plan (JSP), which conveys Secretary Tillerson’s and Administrator Green’s vision for foreign policy and development, based wholly on the President’s commitments to America and its citizens.
- Details
- Written by White House
- Category: National News
Washington, DC - The American people overwhelmingly support taking action to rebuild our nation’s infrastructure.
- Details
- Written by IVN
- Category: National News
Washington, DC - The U.S. Food and Drug Administration Thursday issued a warning letter to Becton Dickinson (BD) & Company that cited several violations of federal law, including marketing significantly modified versions of certain BD Vacutainer blood collection tubes without required FDA clearance or approval and failing to submit medical device reports to the FDA within the required timeframe. These violations were discovered through an inspection of BD’s New Jersey facility. The inspection also showed that the company failed to evaluate and investigate a complaint involving variability in test results observed when certain BD Vacutainer blood collection tubes were used with Magellan Diagnostics’ LeadCare test systems.
Page 79 of 407
